Arich Enterprise Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 11, 2019 at 07:29 pm
Share
Arich Enterprise Co., Ltd. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced total revenue was TWD 241.564 million compared to TWD 316.987 million a year ago. Operating income was TWD 14.615 million compared to TWD 10.970 million a year ago. Net income was TWD 20.241 million compared to TWD 11.979 million a year ago. Basic earnings per share was TWD 0.45 compared to TWD 0.27 a year ago. For the half year, total revenue was TWD 543.390 million compared to TWD 632.922 million a year ago. Operating income was TWD 35.888 million compared to TWD 23.866 million a year ago. Net income was TWD 36.289 million compared to TWD 27.276 million a year ago. Basic earnings per share was TWD 0.81 compared to TWD 0.61 a year ago.
Arich Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the sales and marketing of pharmaceuticals, as well as the provision of the related logistics services. The Company is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The Company also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The Company operates its business mainly within domestic market.
ARICH ENTERPRISE CO., LTD. 
